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Introduction {#sec1}
============

Growth hormone (GH), secreted from the anterior pituitary, has profound effects on the regulation of growth and development throughout the life of mammals ([@bib41], [@bib3]). The biological response of GH is primarily dependent on ligand binding to its membrane receptor, GHR ([@bib19]). *Ghr* is predominantly expressed in the liver, and is also abundant in the fat and muscle. Laron syndrome (LS) is a specific hereditary disease caused by mutations in the *Ghr* gene that leads to GH insensitivity, despite sufficient GH secretion. Patients with LS exhibit short stature, delayed puberty, and truncal obesity ([@bib30], [@bib48]). On the other hand, individuals with LS have very low cancer risk and rarely develop diabetes, implying that *Ghr* is intimately involved in glucose and lipid metabolism ([@bib22]; [@bib29], [@bib24]). These phenotypes of LS are well reproduced in the *Ghr* gene-disrupted mouse model (GHR^−/−^) ([@bib65], [@bib32]). Going from LS to the other extreme, disturbance of glucose metabolism is one of the most common complications in patients with acromegaly with pituitary overproduction of GH. The prevalence and severity of diabetes in patients with acromegaly are considerably higher than those in other populations including people with high risk of diabetes ([@bib16]). Children with height at the upper end of gender- and age-specific scales were found to have greater adult adiposity and a higher risk of obesity onset than their shorter counterparts ([@bib20], [@bib54]). The unexpected uncoupling of obesity and type 2 diabetes observed in LS patients and related animal models prompts researchers to tease apart the exact role of adipose GHR in the multifaceted metabolic control.

The GHR^−/−^ mice exhibit dwarfism, severe postnatal growth retardation, obesity, greatly decreased levels of serum insulin-like growth factor 1 (IGF-1), but elevated levels of GH, and longevity ([@bib32], [@bib65], [@bib4]). Meanwhile, GHR^−/−^ mice display enhanced insulin sensitivity and improved glucose homeostasis, even when challenged with high-fat (HF) diet ([@bib11], [@bib12], [@bib15]). Apart from the global *Ghr*-null models, tissue- and cell-specific *Ghr* knockout in liver ([@bib18], [@bib34]), muscle ([@bib57], [@bib58], [@bib40], [@bib35]), adipose tissues ([@bib33], [@bib36]), macrophage ([@bib38]), cardiac ([@bib25]), and islet β cell ([@bib61]) have been generated in mice, which have provided detailed information on physiological functions of GH signaling in local tissues. Most of the tissue-specific *Ghr* knockout (KO) mice showed similarities to GHR^−/−^ mice ([@bib61], [@bib57], [@bib58], [@bib33], [@bib34], [@bib18], [@bib55]).

The adipose organ is composed of white and brown/beige adipocytes that are respective major sites of energy storage and cold-adapted thermogenesis. White adipose tissue (WAT) is predominately used to store excess energy in the form of triglycerides (TGs) and to provide free fatty acids (FFAs) under conditions of starvation or energy deficiency. In addition, WAT releases several important adipokines to regulate metabolic homeostasis. Cold exposure or β-adrenergic stimulation could induce browning of WAT, which results in a distinct type of fat cells called "beige adipocytes." The increase of beige adipose has anti-obesity and anti-diabetic benefits ([@bib21], [@bib52]). As a thermogenic organ in mammals, brown adipose tissue (BAT) is characterized by a high mitochondrial content to maintain normal body temperature and is involved in energy expenditure ([@bib43]). The mitochondria within BAT are rich in uncoupling protein 1 (UCP1), which can dissipate chemical energy as heat through uncoupling oxidative respiration and ATP synthesis ([@bib10]). Excess expansion of WAT, deficiency of thermogenic capacity, and low expression of *Ucp1* gene in BAT have been linked to obesity and various metabolic diseases ([@bib9], [@bib49], [@bib8], [@bib7]).

The first adipose-specific deletion of *Ghr* mouse model (FaGHRKO) was reported by List et al., using adipocyte protein 2 (aP2) promoter as the Cre recombinase driver ([@bib33]). Both GHR^−/−^ and FaGHRKO mice displayed enlarged fat mass and adipocyte size ([@bib65], [@bib33]). The unexpected mild phenotypes of FaGHRKO, such as altered fat composition, lower circulating IGF-1, and leptin levels ([@bib33]), were soon explained by the leaked activity of the aP2 promoter in many non-adipose cells types including macrophages and skeletal muscle ([@bib59], [@bib31]). Utilization of different Cre mouse deletion strains and variance in diet schemes further confused the phenotype interpretation. Apart from the GHR^−/−^ and FaGHRKO model, an adiponectin-Cre-driving adipocyte-specific GHRKO mice (AdGHRKO) was generated by List et al. during preparation of this study ([@bib36]). The phenotypes of several other tissue-specific GHRKO mouse lines were exacerbated by HF diet ([@bib38], [@bib61]), but both FaGHRKO and AdGHRKO did not try HF treatment. In the present work, we constructed an adiponectin-driven Cre transgenic mouse line (Ad-GHRKO) to attain targeted *Ghr* deletion in adipose. The high specificity and efficacy of the model provided an ideal tool to discern the contribution of adipose GH/GHR to the fat-related metabolic aberrance.

Excessive calorie intake from opulent eating has been fueling the epidemic of metabolic disorders. Therefore the leverage of adipose *Ghr* on susceptibility to dietary obesity and liver lesions was analyzed in this study with particular interest. Recently, GH\'s anti-obesity action has also been reported to be correlated with "browning" of inguinal white adipose ([@bib42]). Less effective adaptive thermogenesis is claimed to be the major cause of failure or the high recidivism rate of weight loss therapy ([@bib17]), in which GH interacts with neuroendocrine hormones and other metabolic and psychobehavioral factors to actively defend body energy storage. BAT thermogenesis in global GHRKO and Ames dwarf mice, the latter being depleted of GH/IGF-1 signaling and thyroid hormone function, were significantly enhanced ([@bib14], [@bib13], [@bib1]). However, the roles of GH in adipose thermogenesis had heavily interfered with systemic changes unrelated to GH action or alterations in multiple hormonal axes in these models. The functional roles of adipose *Ghr* control of adaptive thermogenesis remain unknown, which is the main focus of this study.

Results {#sec2}
=======

Generation and Characterization of Ad-GHRKO Mice {#sec2.1}
------------------------------------------------

Beyond aP2 promoter, adiponectin (Adipoq) promoter serves as a second-generation adipose-targeting driver for gene engineering. We created an adipose-specific *Ghr* gene knockout (Ad-GHRKO) mouse model by crossing GHR-Floxed (Flox) mice with Adipoq-Cre mice ([Figures 1](#fig1){ref-type="fig"}A and 1B). The efficiency and specificity of *Ghr* deletion in the fat pads were validated at DNA and mRNA levels ([Figures 1](#fig1){ref-type="fig"}C and 1D). PCR genotyping with the primers listed in [Table S1](#mmc1){ref-type="supplementary-material"} showed that the Cre activity driven by the Adipoq promoter mediated adipocyte-specific *Ghr* disruption without affecting other tissues ([Figure 1](#fig1){ref-type="fig"}C). The mRNA expression level of *Ghr* was significantly and sufficiently decreased in most adipose tissues ([Figure 1](#fig1){ref-type="fig"}D).Figure 1Generation and Characterization of Adipose-Specific *Ghr* Knockout Mice(A) Schematic diagram of Ad-GHRKO mice construction.(B) PCR genotyping of Flox and KO mice.(C and D) PCR (C) and real-time PCR (D) analyses of *Ghr* expression level in various tissues. Note that a smaller deletion band due to Cre excision was detected only in adipose tissues of KO mice.(E and F) The body weight (E) and increase in body weight (20 weeks versus 4 weeks) (F) of male Ad-GHRKO and Flox mice 20 weeks old.(G) Tissues weight of male Ad-GHRKO and Flox mice 20 weeks old.(H) Serum GH, IGF-1, insulin, blood glucose, and adiponectin levels of 20-week-old male Flox and Ad-GHRKO mice. WT, wild type; Flox, GHR-Floxed; KO, Ad-GHRKO; Het, heterozygote; BAT, brown adipose tissue; SubQ, subcutaneous white adipose tissue; Epi, epididymal white adipose tissue; Peri, perigonadal white adipose tissue; Mes, mesenteric white adipose tissue.All values are presented as mean ± SEM. Statistical significance is shown as \*p ≤ 0.05, \*\*p ≤ 0.01, and \*\*\*p ≤ 0.001. See also [Table S2](#mmc1){ref-type="supplementary-material"}.

To determine the effect of *Ghr* deficiency on body weight and composition, the body and organ weight of 20-week-old mice were measured. Unlike the FaGHRKO mice ([@bib33]), no obvious differences in body weight and increase of body weight were observed between Ad-GHRKO and control mice in the rearing period ([Figures 1](#fig1){ref-type="fig"}E and 1F). Except for the BAT, all the different fat depots examined in Ad-GHRKO mice were heavier than the control ([Figure 1](#fig1){ref-type="fig"}G). Among them, the subcutaneous (subQ) WAT had the largest increase of weight, whereas the liver was markedly lighter and the weights of other tissues like the heart, kidney, and pancreas were slightly reduced in Ad-GHRKO mice ([Figure 1](#fig1){ref-type="fig"}G). We calculated the sum of the weight increase of the WAT fat pads and the weight decrease in the liver, heart, kidney, and pancreas. The results showed that the Ad-GHRKO mice had 0.996 ± 0.162 g weight gain in WAT, which was not equal to the 0.456 ± 0.194 g weight loss in other organs altogether. Among these organs, the liver was the only one displaying a significant decrease. Although other body parts such as muscles and bone were not measured, we concluded that the decreased liver weight was the principal, but not the only factor contributing to the unchanged body weight of Ad-GHRKO mice. Serological detection indicated that loss of *Ghr* in adipose tissues had little effect on circulating GH and IGF-1 levels in Ad-GHRKO mice ([Figure 1](#fig1){ref-type="fig"}H). Serum insulin, blood glucose levels, and adiponectin level also do not display any notable differences between 20-week-old Ad-GHRKO and Flox mice ([Figure 1](#fig1){ref-type="fig"}H).

The Absence of Adipose *Ghr* Exacerbated Diet-Induced Obesity but Improved Glucose Homeostasis {#sec2.2}
----------------------------------------------------------------------------------------------

The weight gain of both Ad-GHRKO mice and the control littermates stayed in step with each other under regular chow, whereas an incrementally enlarged gap emanated between the two groups when fed with HF diet for 16 weeks (HF diet feeding was started from age 8 weeks) ([Figures 2](#fig2){ref-type="fig"}A--2C). Anatomical dissections revealed that the heavier body weight in Ad-GHRKO mice mainly originated from more weight gain in adipose tissues, especially the subcutaneous, perirenal, and mesenteric WAT ([Figure 2](#fig2){ref-type="fig"}D).Figure 2Ad-GHRKO Exacerbates Dietary Obesity but Improves Glucose Homeostasis during HF Feeding(A) Representative photographs of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(B)The growth curves of Ad-GHRKO and Flox mice during RC or HF feeding.(C) Increase in body weight (24 weeks versus 4 weeks) of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(D) Fat tissue weight of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(E and F) Fasting blood glucose levels of Ad-GHRKO and Flox mice fed with HF for 8 (E) and 16 weeks (F).(G--J) Glucose tolerance test and insulin tolerance test of Ad-GHRKO and Flox mice fed with HF for 8 (G and H) and 16 weeks (I and J). Inset: The area under curves.All values are presented as mean ± SEM. Statistical significance is shown as \*p ≤ 0.05, \*\*p ≤ 0.01, and \*\*\*p ≤ 0.001. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc1){ref-type="supplementary-material"}.

It has been reported that GHR^−/−^ and AdGHRKO mice exhibited healthy adipose expansion with improved insulin sensitivity ([@bib37], [@bib12], [@bib2], [@bib36]), whereas the basal glucose homeostasis of FaGHRKO mice was not changed ([@bib33]). In good agreement with this, no significant difference was found in the serum glucose level in mice with or without adipose *Ghr* deletion, when fed with regular chow (RC). After loading with HF diet for 8 weeks, fasting blood glucose level in Ad-GHRKO mice was significantly lower than in Flox mice (KO 8.31 ± 1.18 mmol/L versus Flox 11.34 ± 0.44 mmol/L) ([Figure 2](#fig2){ref-type="fig"}E). Glucose tolerance test and insulin tolerance test assays revealed that Ad-GHRKO mice were more sensitive to insulin stimulation than control littermates after 8 weeks of HF diet ([Figures 2](#fig2){ref-type="fig"}G and 2H). With prolonged HF diet for 16 weeks, the fasted blood glucose level in Ad-GHRKO mice was still lower than that of the control mice (KO 8.63 ± 1.28 mmol/L versus Flox 10.26 ± 1.06 mmol/L) ([Figure 2](#fig2){ref-type="fig"}F), and Ad-GHRKO mice responded better to glucose challenge ([Figure 2](#fig2){ref-type="fig"}I) but no longer showed advantage in insulin sensitivity ([Figure 2](#fig2){ref-type="fig"}J). Overall, these results indicated that defective adipose GH signaling rescued, to a significant degree, the mice from hyperglycemia and insulin resistance imposed by oversupplied nutrients.

An Integration of Lipolysis, Lipogenesis, and Adipogenesis Magnified the HF-Induced Obesity and Limited FFA Liberation in Ad-GHRKO Mice {#sec2.3}
---------------------------------------------------------------------------------------------------------------------------------------

The obesity in GHR^−/−^, FaGHRKO, and AdGHRKO mice was attributed to fat expansion in both number and size of adipocytes ([@bib65], [@bib2], [@bib33], [@bib36]). As we expected, the subQ WATs of Ad-GHRKO mice were significantly larger than those of the control littermates when fed with RC, which was exaggerated by HF diet treatment ([Figures 3](#fig3){ref-type="fig"}A--3C). Furthermore, we examined the expression levels of lipid metabolism-related genes (Primers are listed in [Table S1](#mmc1){ref-type="supplementary-material"}) and proteins. As expected, lipolysis-related genes (e.g., *Atgl*, *Hsl*, *Mgl*) were down-regulated, whereas genes involved in lipogenesis (e.g., *Pparγ*, *Acc1*, *Fas*) were up-regulated ([Figure 3](#fig3){ref-type="fig"}D) in subQ WAT of KO mice. The expression of *Fsp27* gene, which encodes fat-specific protein 27 (Fsp27) and is an important positive regulator for fat droplet formation, was significantly higher in Ad-GHRKO mice than in the controls, especially when challenged with HF diet ([Figure 3](#fig3){ref-type="fig"}D). Consistently, the western blot results showed that deficiency of *Ghr* in adipose tissues dramatically enhanced the levels of ACC1, FAS, SREBP1, and PPARγ ([Figure 3](#fig3){ref-type="fig"}E). Although higher circulatory FFAs are commonly detected in obese individuals owing to expanded fat mass, serum FFA levels were comparable in the Ad-GHRKO versus control mice ([Figure 3](#fig3){ref-type="fig"}F). More intriguingly, despite the augmented obesity after HF diet, the FFA release of Ad-GHRKO mice was only mildly elevated by excessive feeding and was significantly lower than that of the HF-fed Flox control ([Figure 3](#fig3){ref-type="fig"}F). The data implied that lack of GHR in adipose improved local FFA recycling, which could provide a beneficial FFA buffering for systemic glucose metabolism and ectopic fat deposition in the liver.Figure 3Ad-GHRKO Causes Lipid Accumulation in WAT and BAT(A) Representative images of SubQ WAT from 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks). Scale bar, 1 cm.(B) H&E staining of SubQ WAT from 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks). Scale bar, 100 μm.(C) Quantification of adipocyte area of SubQ WAT.(D) Relative expression levels of genes related to lipolysis and lipogenesis in SubQ WAT from 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(E) The levels of selected proteins in SubQ WAT of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(F) Serum FFA levels of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(G) BAT sections stained with H&E in 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks). Scale bar, 100 μm.(H) Relative expression levels of genes related to thermogenesis and lipogenesis in BAT of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(I) Immunostaining of BAT sections with anti-UCP-1 antibody. Scale bar, 100 μm.All values are presented as mean ± SEM. Statistical significance is shown as \*p ≤ 0.05, \*\*p ≤ 0.01, and \*\*\*p ≤ 0.001. See also [Table S2](#mmc1){ref-type="supplementary-material"}.

Histology analysis showed that lipid droplet expansion and accumulation were displayed in BAT of Ad-GHRKO mice ([Figure 3](#fig3){ref-type="fig"}G). Compared with the Flox mice, the Ad-GHRKO mice had greatly increased expression of genes involved in fatty acid synthesis and lipid droplet accumulation (e.g., *Ppar-γ*, *Cidea,* and *Fsp27*) in BAT ([Figure 3](#fig3){ref-type="fig"}H). Meanwhile, the expression levels of thermogenic genes such as *Pgc1α*, *Prdm16,* and *Ucp1* were significantly reduced in BAT by GHR deletion ([Figure 3](#fig3){ref-type="fig"}H). Consistent with the mRNA data, the staining of BAT UCP1 was significantly lower in Ad-GHRKO mice than in the controls, especially when challenged with HF diet ([Figure 3](#fig3){ref-type="fig"}I).

Not only adipocyte hypertrophy but also hyperplasia through activation of the adipogenic SVF cells contributes to obesity. SVF cells are a mixed cell population rich in pre-adipocytes, mesenchymal stem cells, and various inflammatory cells ([@bib50], [@bib47]). The effect of *Ghr* disruption on adipocyte regeneration was determined by adipogenic differentiation of SVF cells separated from adipose tissues, *in vitro*. Consistent with *in vivo* experiments, the SVF cells isolated from WAT and BAT of KO mice showed higher differentiation potential ([Figures 4](#fig4){ref-type="fig"}A and 4B). Palmitic acid treatment, which simulated fatty acid influx, dose dependently increased the lipid droplets formation in the WAT SVF cells derived from Ad-GHRKO mice ([Figure 4](#fig4){ref-type="fig"}A). In addition, significant decreases in lipolysis gene (e.g., *Atgl*, *Hsl*) and increases in lipogenesis gene (e.g., *Acc*, *Fas*, *Fsp27*) expressions were observed in WAT SVF of Ad-GHTKO mice ([Figure 4](#fig4){ref-type="fig"}C). The results confirmed the participation of adipocyte differentiation in WAT expansion in adipose GHR-depleted mice. Meanwhile, SVF cells separated from BAT of Ad-GHRKO mice were more easily differentiated into adipocytes with lower expression levels of thermogenesis genes (e.g., *Ucp1*, *Pgc1a*) and lipolysis genes (e.g., *Atgl*, *Hsl*) and higher expression levels of lipogenesis genes (e.g., *Acc*, *Fas*, *Cidea*) than of the Flox mice ([Figure 4](#fig4){ref-type="fig"}D). Based on these results, we speculated that GHR could be required in the BAT thermogenic process, which is assessed in a later sector in the study.Figure 4Deletion of *Ghr* in Adipocytes Promotes Adipogenic Differentiation of SVF Cells(A) Induced adipogenic differentiation of SVF cells from subQ WAT of 20-week-old male Ad-GHRKO and Flox mice. Scale bar, 50 μm.(B) Induced adipogenic differentiation of SVF cells from BAT of 20-week-old male Ad-GHRKO and Flox mice. Scale bar, 50 μm.(C) Expression of *Ghr* and genes related to lipolysis and *de novo* lipogenesis in SVF cells from subQ WAT of 20-week-old male Ad-GHRKO and Flox mice.(D) Expression of *Ghr* and genes related to thermogenesis, lipolysis, and *de novo* lipogenesis in SVF cells from BAT of 20-week-old male Ad-GHRKO and Flox mice.All values are presented as mean ± SEM. Statistical significance is shown as \*p ≤ 0.05, \*\*p ≤ 0.01 and \*\*\*p ≤ 0.001.

Ad-GHRKO Mice Were More Resistant to HF-Induced Hepatic Steatosis {#sec2.4}
-----------------------------------------------------------------

GH-stimulated hepatic secretion is the primary source of circulating IGF-1 ([@bib53]). Serum levels of GH and IGF-1 have been shown to correlate with hepatic fat accumulation ([@bib6]). As a major site of lipogenesis and lipid oxidation, the liver is the central engine modulating whole-body metabolic homeostasis and is vulnerable to nutritional damage. We found that both the liver mass and liver index of Ad-GHRKO groups were significantly lower than those of the Flox mice, with or without HF diet stimuli ([Figures 5](#fig5){ref-type="fig"}A and 5B). Furthermore, deletion of *Ghr* in adipose brought down the liver TG contents significantly by 26.7% and 11.5% in mice fed with RC and HF for 16 weeks ([Figure 5](#fig5){ref-type="fig"}C), respectively. However, no apparent differences under RC condition were observed in hepatic histopathology by H&E and oil red O staining ([Figure 5](#fig5){ref-type="fig"}E). A significant increase of hepatic steatosis marked by vacuolated and lipid-laden hepatocytes was observed in both groups fed with HF for 16 weeks, but more manifest in the Flox mice than Ad-GHRKO mice ([Figure 5](#fig5){ref-type="fig"}E). The histopathologic changes and lipid deposit ([Figure S1](#mmc1){ref-type="supplementary-material"}A, indicated by black arrows) occurred evidently in the liver of the Flox mice after only 8 weeks of HF feeding but not of the Ad-GHRKO mice ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Periodic acid-Schiff reaction of liver tissues showed that Ad-GHRKO mice have stronger glycogen synthesis capacity ([Figure S1](#mmc1){ref-type="supplementary-material"}). The improvement of hepatic glycogen synthesis in Ad-GHRKO mice was conducive to the maintenance of blood glucose levels during HF feeding ([Figures 2](#fig2){ref-type="fig"}E and 2F). β-Hydroxybutyric acid (β-HBA) is the ketone body that indicates liver uptake of FFAs because it can only be produced from the mitochondrial β-oxidation of FFAs in the liver. Indeed, the serum β-HBA level in the HF-fed Ad-GHRKO mice was significantly lower than that in the Flox mice ([Figure 5](#fig5){ref-type="fig"}D). In conjunction with the lower FFA availability in Ad-GHRKO mice ([Figure 3](#fig3){ref-type="fig"}F), the results further demonstrated that an adipose FFA trapping is the mechanism underlying the hepatic protection against HF. The release of a variety of hepatic inflammation markers such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) is a biochemical sign indicating the loss of hepatocellular integrity. Compared with control littermates, a significant reduction in relative activity of both AST and ALT was observed in Ad-GHRKO mice fed with HF ([Figure 5](#fig5){ref-type="fig"}F). The influence of adipose *Ghr* deficiency on lipid profile was examined by measuring the serum triglyceride (TG), total cholesterol (T-CHO), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) values. Despite the comparable baseline concentrations, the serum TG, T-CHO, and LDL-C in Ad-GHRKO groups were still significantly lower than in Flox mice under HF diet condition ([Figures 5](#fig5){ref-type="fig"}G--5J), confirming a suppressed development of hyperlipidemia in Ad-GHRKO mice.Figure 5Ad-GHRKO Alleviates Hepatic Steatosis during HF Feeding(A--C) Liver mass (A), liver index (liver weight/body weight %) (B), and liver triglyceride content (C) of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(D) Serum β-HBA levels of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(E) H&E and oil red O staining of liver sections of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks). Scale bar, 100 μm.(F) Serum AST and ALT activity of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(G--J) Serum TG (G), T-CHO (H), LDL-C (I), and HDL-C (J) levels of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(K) Relative gene expression levels in livers of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).(L) Western blot analysis of proteins involved in *de novo* lipogenesis, lipolysis, β-oxidation, and FFA uptake in livers of 24-week-old male Ad-GHRKO and Flox mice (HF fed for 16 weeks).All values are presented as mean ± SEM. Statistical significance is shown as \*p ≤ 0.05, \*\*p ≤ 0.01, and \*\*\*p ≤ 0.001. See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc1){ref-type="supplementary-material"}.

In light of the findings of less lipid accumulation in the liver and a shrinking lipid and FFA reservoir in the circulation of Ad-GHRKO mice, we investigated whether the hepatic lipid turnover was directly altered. Compared with Flox mice under the same diet condition, the expression levels of lipogenic genes in the liver of Ad-GHRKO were slightly lower or even had no significant changes (e.g., *Acc-1*, *Fas*), whereas the expression of genes involved in lipolysis (e.g., *Atgl*, *Hsl*, *Mgl*) were markedly increased with statistical significance ([Figure 5](#fig5){ref-type="fig"}K). There were no significant differences in the expression of *Pparα*, *Cpt2,* and *Atp5a*. Down-regulation of *Cpt1b* and *Fabp3* was detected in KO mice fed HF or RC diet ([Figure 5](#fig5){ref-type="fig"}K). We further found that the expression levels of genes related to fatty acid uptake, such as *Cd36* and *Fbtp2,* were significantly lower in Ad-GHRKO than in Flox mice under HF diet condition ([Figure 5](#fig5){ref-type="fig"}K). In contrast to the Ad-GHRKO mice, the protein abundances of FAS and CD36 displayed a striking increase in Flox mice when fed with HF diet ([Figure 5](#fig5){ref-type="fig"}L). Meanwhile, the levels of PPARα and ATGL, responsible for fatty acid disposal and lipolysis, respectively, were up-regulated in Ad-GHRKO mice, especially when challenged with HF diet ([Figure 5](#fig5){ref-type="fig"}L). Phospholipids are the main components of lipid and are involved in adipogenesis. Lipin1 is known as a phosphatidic acid phosphohydrolase enzyme that catalyzes the conversion of phosphatidate to diacylglycerol in the cytoplasm ([@bib23], [@bib46]). Lipin1 is also expressed as a nuclear transcriptional coactivator to modulate the expression of other genes involved in lipid metabolism ([@bib44]). Up-regulation of Lipin 1 is implicated in hepatic steatosis. As we expected, the basal and HF-stimulated Lipin1 expression were higher in Flox mice than in Ad-GHRKO mice ([Figure 5](#fig5){ref-type="fig"}L). These results coalesced to demonstrate that the adipose-tissue-specific ablation of *Ghr* protected the liver from diet-induced steatosis via the sum of promoted lipolysis and dampened lipogenesis at both transcriptional and translational levels. Most importantly, the absence of adipose *Ghr* pathway trapped fatty acid locally in WAT and thereby restrained the fatty acid delivery necessary for lipid production in the liver.

Adipose *Ghr* Signaling Was Required in the Cold-Stimulated Adaptive Thermogenesis {#sec2.5}
----------------------------------------------------------------------------------

The high expression level of UCP1 is closely related to reduced body weight and increased insulin sensitivity ([@bib28], [@bib7]). PGC1α is a transcription co-activator related to mitochondrial function and adaptive thermogenesis ([@bib45]). As we had observed above, BAT of Ad-GHRKO mice showed a "whitening" trend ([Figure 3](#fig3){ref-type="fig"}G). Besides, a down-regulation of thermogenic genes such as *Pgc1α*, *Prdm16,* and *Ucp1* was detected in BAT tissue ([Figure 3](#fig3){ref-type="fig"}H) and BAT-originated SVF cells ([Figure 4](#fig4){ref-type="fig"}D) of Ad-GHRKO mice. Consistent with mRNA data, protein levels of UCP1 were significantly reduced in BAT of Ad-GHRKO mice, especially in HF-feeding condition ([Figure 3](#fig3){ref-type="fig"}I). H&E staining showed that cold exposure reduced the lipid accumulation in BAT of Ad-GHRKO mice, but qPCR and immunohostochemistry analysis demonstrated that the expression levels of UCP1 and PGC1α were still lower in BAT of KO mice than in Flox mice ([Figures 6](#fig6){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}A). As UCP1 is the key mediator in adaptive thermogenesis, its down-regulation in Ad-GHRKO mice implied the potential involvement of GHR in energy expenditure and emergent heat generation.Figure 6Ad-GHRKO Impairs Thermogenic Function and Significantly Inhibits Browning of SubQ WAT under Cold Stress(A) H&E and Immunostaining of BAT from 16-week-old male Ad-GHRKO and Flox mice at room temperature or after 9-day cold stimulation. Scale bar, 100 μm.(B) Body temperature of 16-week-old male Ad-GHRKO and Flox mice in the first day of cold stimulation.(C) Body temperature recovery of 16-week-old male Ad-GHRKO and Flox mice at 25°C after first day of cold stimulation.(D) Body weight reduction of 16-week-old Ad-GHRKO and Flox mice over 9-day cold stimulation.(E) SubQ WAT mass of 16-week-old Ad-GHRKO and Flox mice over 9-day cold stimulation.(F) Representative images of subQ WAT from 16-week-old male Ad-GHRKO and Flox mice at room temperature or after 9-day cold stimulation. Scale bar, 1 cm.(G) H&E and Immunostaining of subQ WAT from 16-week-old male Ad-GHRKO and Flox mice at room temperature or after 9-day cold stimulation. Scale bar, 100 μm.All values are presented as mean ± SEM. Statistical significance is shown as \*p ≤ 0.05 and \*\*p ≤ 0.01. See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.

To test the hypothesis, the mice were stressed under 4°C on a 10-/14-h cycle for 9 days and body temperature changes were recorded. On the first day of the experiment, the rectal temperature of RC-fed Ad-GHRKO mice dropped more sharply than that of the Flox mice during the cold exposure (KO 26.15 ± 2.34°C versus Flox 31.06 ± 2.86°C at the end of 10-h exposure) ([Figure 6](#fig6){ref-type="fig"}B). Consistently, the rectal temperatures of KO mice also recovered more slowly in room temperature after cold acclimation ([Figure 6](#fig6){ref-type="fig"}C). However, in the mouse groups fed with HF diet for 8 weeks, adipose *Ghr* knockout had no impact on the decrease and recovery rates of the rectal temperature ([Figures 6](#fig6){ref-type="fig"}B and 6C, dashed lines). The cold endurance of all four groups of mice, with deficient or intact adipose *Ghr* and regardless of the diet, had no significant difference in the fluctuations of body temperature from the second to the ninth day of cold induction ([Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}). In addition, the Flox control lost more weight following cold stimulation than the Ad-GHRKO mice, under both HF and RC feeding conditions ([Figure 6](#fig6){ref-type="fig"}D). When subQ WAT mass was examined, the cold acclimation only caused statistically significant weight reduction in the Flox mice, not the Ad-GHRKO mice ([Figure 6](#fig6){ref-type="fig"}E). The browning capacity of WAT of Ad-GHRKO mice in response to cold stimulation for 9 days was also impaired as shown by the remarkable darkening of the subQ fat tissues of the Flox mice, but not the Ad-GHRKO mice ([Figure 6](#fig6){ref-type="fig"}F). Histological examination revealed that the cold-Flox-RC group had a new population of "beige" fat cells, which contain multiple small lipid droplets and high levels of UCP1 and PGC1α, which was not detected in the cold-KO-RC group ([Figure 6](#fig6){ref-type="fig"}G). Consistently, the expression of marker genes of beige and thermogenesis in subQ WAT ([Figure S2](#mmc1){ref-type="supplementary-material"}B) and epi WAT ([Figure S2](#mmc1){ref-type="supplementary-material"}C) were declined in Ad-GHRKO mice. These results confirmed the requirement of adipose GHR for emergent heat production and cold adaptation.

Discussion {#sec3}
==========

GH is dubbed as an anti-obesity hormone for its actions of promoting lipolysis and inhibiting lipogenesis ([@bib56]). Apart from the GHR^−/−^ mice with global *Ghr* deletion and the FaGHRKO model, almost simultaneously and identical to our own design, an AdGHRKO model was generated by List et al. ([@bib33], [@bib36]). These models not only represent a longitudinal technique updating but also have made valuable attempts to describe the pleiotropic role of adipose GH/GHR from different perspectives. Taking the great chance to compare the phenotypes of these four mouse lines ([Table S2](#mmc1){ref-type="supplementary-material"}), we found that the basal metabolic parameters of our Ad-GHRKO mice were overly parallel to List et al.'s AdGHRKO mice. Metabolic alterations in adipose tissues and at the systemic level in both male and female AdGHRKO mice were reported, whereas sexual dimorphism was avoided in the present study by examining only male subjects. Also, we particularly focused on the response of Ad-GHRKO mice to the metabolic stress of HF feeding and cold acclimation, which was not studied in both FaGHRKO and AdGHRKO mice.

In agreement with the AdGHRKO and in contrast to the GHR^−/−^ mice, the endocrine production of GH and IGF-1 were not intervened by adipose *Ghr* deletion in our Ad-GHRKO mice, and the serum glucose levels were not affected under RC feeding. In clinical and mouse model studies, GH-deficient individuals are more likely to develop insulin resistance and fatty liver ([@bib63], [@bib5]). A concurrence of excessive WAT fat deposition and reduction of liver weight was described in both AdGHRKO ([@bib36]) and our Ad-GHRKO mice, which counteract each other to retain a balanced body weight. Lowered liver weight was mainly attributed to the reduction of TG content. The most striking characteristic of Ad-GHRKO mice was that this hepatic protection was dramatically accentuated by HF feeding. Loss of adipose *Ghr* exacerbated subcutaneous obesity but inhibited ectopic adiposity in the liver and muscle tissues, another preferred site of pathological fat deposition ([Figure S5](#mmc1){ref-type="supplementary-material"}). The serum lipid index and liver function markers, such as AST and ALT, were correspondingly less affected by dietary overloading in mice lacking adipose *Ghr*. In the study of AdGHRKO mice, the causes of the inhibition of liver steatosis were postulated as declined serum insulin concentration and improved insulin sensitivity. However, differing from the AdGHRKO mice, the baseline insulin level was unchanged in our Ad-GHRKO model and the enhanced insulin sensitivity was only observed after the mice were subjected to HF. This implies that the insulin response may protect the liver from adverse environmental cues, but other mechanisms must be also operating.

The adipocyte-produced, insulin-sensitizing hormone adiponectin is inversely associated with many metabolic disorders. Circulating levels of adiponectin were elevated in GHR^−/−^ mice ([@bib32], [@bib39]) but decreased in the FaGHRKO and the AdGHRKO mice ([@bib33], [@bib36]). However, the regulation of adiponectin to improve insulin sensitivity may be overridden by the divergent adipokine profile displayed in the AdGHRKO mice, as no impact of systemic glucose tolerance and insulin sensitivity was found. Interestingly, in our Ad-GHRKO mice, although adiponectin secretion was stable under RC ([Figure 1](#fig1){ref-type="fig"}H), it was more profoundly stimulated by HF diet in the Ad-GHRKO mice than in the control mice (Flox 5,758.4 ± 125.2 ng/mL versus KO 6,622.9 ± 703.6 ng/mL). The amplified expansion of adipocyte size (hypertrophy) and number (hyperplasia) might lead to elevated adiponectin secretion, which correlated with improved insulin sensitivity.

By analyzing the lipogenic and lipolytic factors at both genetic and protein levels, and the adipocyte differentiation of SVF cells *in vitro*, we found that GH/GHR acted as the master regulator of the comprehensive lipid-producing machinery. The absence of adipose *Ghr* overwhelmingly based WAT-dominant obesity in Ad-GHRKO mice. Losing GHR control, the privileged local fat production in adipose, especially in subQ WAT, limited FFA availability to the liver and muscle by depleting substrate supply. The significant decline of β-HBA synthesis further verified the lower level of FFA disposal in the liver of Ad-GHRKO mice. Suppressed FFA releasing into the circulation, accompanied by accelerated TG clearance and FFA uptake in adipose, is a phenomenon documented in some forms of obesity ([@bib27]). On the other hand, an impaired peripheral FFA trapping was supposed to be the etiology of insulin resistance, dyslipidemia, and liver diseases secondary to HIV lipodystrophy ([@bib60]). We propose a mechanism of FFA trapping in adipose tissue to prevent ectopic adiposity as a good trade-off of excessive fat hoarding in adipose, where *Ghr* plays an instrumental part ([Figure 7](#fig7){ref-type="fig"}).Figure 7Schematic Summary of the Local and Systemic Impacts of Adipose *Ghr* Deletion, in Response to Metabolic StressDisruption of *Ghr* in adipose tissue significantly increases *de novo* lipogenesis and facilitates the lipid droplet fusion in both WAT and BAT. Excessive local adiposity resulting from HF diet constitutes an adipose FFAs trapping effect that spares dietary liver damage via limited FFA availability and liver FFA uptake. Meanwhile, lacking adipose *Ghr* causes a less effective adaptive thermogenic response to acute cold stimulation, whereas the body temperature under chronic cold stress can be stabilized by thermal insulation from subcutaneous fat compensation.

The communication between adipose and liver, in respect of lipid metabolism and glucose homeostasis, has been investigated with different genetic engineering animal models. Some adipose-specific deletions of downstream post-receptor effectors of GH such as STAT5 in mice were studied and discussed ([@bib26]), but thus far the AdGHRKO and our Ad-GHRKO are the only mouse lines that underscored a clear-cut role of adipose GHR in fat draining from the liver to the adipose. The interorgan metabolic communication was also studied using genetically engineered animals lacking the key enzymes catalyzing lipolysis. The adipose-specific deletion of *Hsl*, rather than liver-specific *Hsl* deficiency, led to age-dependent lipodystrophy and liver steatosis ([@bib62]), whereas intriguingly adipose-specific *Atgl*-KO mice had an opposite effect of reducing liver steatosis and improving hepatic insulin signaling ([@bib51]). A similar liver protection from HF stress was reported in a systemic *Mgl-*KO mouse model, accompanied by appetite suppressing and decreased intestinal fat absorption ([@bib64]).

The adaptive non-shivering thermogenesis mediated by UCP1-dependent activity in BAT is one of the facultative heat-producing strategies taken by mammals, especially in small animals, including rodents and infant humans, in response to limited nutrition supply or cold environment. Unlike the Ames dwarf mice and GHRKO mice, our Ad-GHRKO mice were less successful in maintaining normothermia, with declined gene expression and protein level of UCP1 and its regulator *Pgc1α*. WAT can acquire energy-burning potential by a "browning" process during which the white fat is converted into "beige." Stimulations activation of WAT browning includes endogenous hormonal regulation and exogenous stress, typically cold. The extra energy expenditure raised from WAT browning is recently proposed to be anti-obesity ([@bib10], [@bib21]). Consistent with recent data indicating that GH is able to promote WAT browning through activation of STAT5 ([@bib42]), we found that *Ghr* ablation in adipose tissues was able to inhibit browning of subQ WAT under cold stimulation. In Ad-GHRKO mice, the contained heat dissipation by BAT and the inhibited WAT browning conspired to safeguard the fat storage attained from intensive energy intake. During the lipolysis processes, TGs from WAT are hydrolyzed into glycerol and FFAs. These FFAs then enter the mitochondria for lipid oxidation aimed to heat production. The low expression levels of lipolysis genes in WAT of Ad-GHRKO mice led to the decrease of circulating FFAs, which could restrict the calorie sources of KO mice. Vice versa, the redundant subQ white fat formed an insulation layer to assist Ad-GHRKO mice against cold, which might justify the transient impairment of temperature maintenance in Ad-GHRKO mice.

In summary, aided by the Ad-GHRKO mouse model, we were able to test the distinct roles of adipose GHR in response to metabolic stress represented by HF feeding and cold acclimation. Defective adipose *Ghr* action endowed the mice with healthy fat storage in WAT: trapping fat within adipose tissues spared the liver from steatosis. However, "healthy" obesity was developed at the expense of impaired cold endurance and WAT browning ([Figure 7](#fig7){ref-type="fig"}). For populations feeding on a diet densely packed with calories, the double dictation of adipose GHR in both the metabolic dysfunctions centered at liver damage and the therapeutic or cosmetic weight management is of far-reaching interest. More mechanistic investigation of adipokines and cross-organ FFA messaging in the setting of GHR manipulation, in particular, generation of a liver- and adipose-specific double GHRKO mouse model is our immediate endeavor.

Limitations of the Study {#sec3.1}
------------------------

The most significant evidence provided by this study is that adipose deletion of *Ghr* inhibited ectopic adiposity, especially in the liver, with a trade-off of subcutaneous fat expansion. However, there are several limitations owing to constraints on methodology and the scope of the research. (1) The inherent problem of the flox/Cre mouse model we used for adipose-specific *Ghr* knockout is that it did not provide platforms to discern the regulations of GH in metabolism from organ development, which could be achieved by temporally controlled *Ghr* knockout in mature or young growing animals using, e.g., tamoxifen-inducible technique. (2) Despite high specificity, Cre recombination efficiency in our Cre mouse line was not ideal, which might arise from the less-sensitive floxed allele and the critical roles GHR plays in adipogenesis and potentially cell survival of adipocytes themselves. (3) Experiments could have been performed to tease apart the different contributions of GHR in subcutaneous (SAT) versus visceral fat (VAT) to liver metabolism, such as fat tissue from a certain depot in Ad-GHRKO mouse could be transplanted into control mouse and the results would tell us if GHR signalings in SAT and VAT cooperate or counteract each other in metabolic regulations.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods, Figures S1--S5, and Tables S1 and S2

This work was supported by the National Natural Science Foundation of China (No. 81600668; No. 81471000l); the Ministry of Science and Technology of China (No. 2014DFA32120); and Research Project of Educational Commission of Liaoning, China (No.L2016023).

Author Contributions {#sec5}
====================

Y.W. and L.R. conceived the study, designed the experiments, and wrote the manuscript. L.R. and X.W. performed experiments and collected and analyzed data. A.M., Y.L., and H.W. performed cold and cell experiments. J.W., J.S., and B.L. assisted with the qPCR and western Blot. M.G., D.W., W.G., and Y.L. performed animal breeding. R.J. and N.W. assisted with histological experiments. L.Z., L.H., X.C., B.L., and X.L. also designed the experiments and involved in discussion and writing the manuscript. L.Z., D.L., and X.L. provided language help. All authors reviewed the manuscript.

Declaration of Interests {#sec6}
========================

The authors declare no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.isci.2019.05.020>.

[^1]: These authors contributed equally

[^2]: Lead Contact
